Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients.

Front Oncol · 2020 · PMC7917249 · PMID 33659205

Europe PMC DOI

hedged sentence

0.4100

closest p · 8.2× alpha

0.4100

boldest claim

The sentences

did not reach statistical significancep = 0.41not close (p > 0.1)

26%), although it did not reach statistical significance (p = 0.41).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.